Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SG 301

Next Previous
Drug Profile

SG 301

Alternative Names: SG-301; SG-301 SC

Latest Information Update: 20 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hangzhou Sumgen Biotech
  • Class Antineoplastics; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; CD38 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Multiple myeloma
  • Phase II Idiopathic thrombocytopenic purpura; Systemic lupus erythematosus
  • Phase I Haematological malignancies

Most Recent Events

  • 17 Aug 2026 Hangzhou Sumgen Biotech plans a phase-II trial for Renal transplant rejection in China (IV, infusion) in September 2026 (NCT07764627)
  • 11 Jun 2026 Phase-II clinical trials in Idiopathic thrombocytopenic purpura (Treatment-experienced) in China (SC) (NCT07710248)
  • 26 Mar 2026 Phase-II clinical trials in Systemic lupus erythematosus (Treatment-resistant) in China (SC) (NCT07447986)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top